322 related articles for article (PubMed ID: 19058999)
21. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
Enders M; Weidner A; Zoellner I; Searle K; Enders G
Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
[TBL] [Abstract][Full Text] [Related]
22. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma.
Li Y; Wang J; Zhu G; Zhang X; Zhai H; Zhang W; Wang W; Huang G
Am J Gastroenterol; 2007 Jul; 102(7):1489-98. PubMed ID: 17459020
[TBL] [Abstract][Full Text] [Related]
23. Parvovirus infection: an immunohistochemical study using fetal and placental tissue.
Li JJ; Henwood T; Van Hal S; Charlton A
Pediatr Dev Pathol; 2015; 18(1):30-9. PubMed ID: 25361230
[TBL] [Abstract][Full Text] [Related]
24. Parvovirus B19 caused fetal death: a case report in Thailand.
Booncharoen P; Boonpasat Y; Sriurairatana S
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S12-6. PubMed ID: 10865400
[TBL] [Abstract][Full Text] [Related]
25. Parvovirus infects cardiac myocytes in hydrops fetalis.
O'Malley A; Barry-Kinsella C; Hughes C; Kelehan P; Devaney D; Mooney E; Gillan J
Pediatr Dev Pathol; 2003; 6(5):414-20. PubMed ID: 14708734
[TBL] [Abstract][Full Text] [Related]
26. Maternal-fetal transmission of human parvovirus B19 genotype 3.
Candotti D; Danso K; Parsyan A; Dompreh A; Allain JP
J Infect Dis; 2006 Sep; 194(5):608-11. PubMed ID: 16897659
[TBL] [Abstract][Full Text] [Related]
27. [Parvovirus B19 infection in hydrops fetalis].
Kaiser L; Sükösd F; Veszprémi B; Arany A; Vizer M; Szabó I; Kisfaludy N; Magyar E; Pajor L
Orv Hetil; 2000 Jul; 141(30):1661-5. PubMed ID: 10962903
[TBL] [Abstract][Full Text] [Related]
28. Association of hypospadias and cardiac defect in a Parvovirus B19-infected stillborn: a causality relation?
Konstantinidou AE; Syridou G; Spanakis N; Tsakris A; Agrogiannis G; Patsouris E
J Infect; 2007 Jan; 54(1):e41-5. PubMed ID: 16712940
[TBL] [Abstract][Full Text] [Related]
29. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.
Enders M; Weidner A; Rosenthal T; Baisch C; Hedman L; Söderlund-Venermo M; Hedman K
J Infect Dis; 2008 Jan; 197(1):58-62. PubMed ID: 18171285
[TBL] [Abstract][Full Text] [Related]
30. PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics.
Bonvicini F; Mirasoli M; Gallinella G; Zerbini M; Musiani M; Roda A
Analyst; 2007 Jun; 132(6):519-23. PubMed ID: 17525808
[TBL] [Abstract][Full Text] [Related]
31. Parvovirus B19 infection.
Tolfvenstam T; Broliden K
Semin Fetal Neonatal Med; 2009 Aug; 14(4):218-21. PubMed ID: 19231308
[TBL] [Abstract][Full Text] [Related]
32. Different patterns of restriction to B19 parvovirus replication in human blast cell lines.
Gallinella G; Manaresi E; Zuffi E; Venturoli S; Bonsi L; Bagnara GP; Musiani M; Zerbini M
Virology; 2000 Dec; 278(2):361-7. PubMed ID: 11118359
[TBL] [Abstract][Full Text] [Related]
33. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus.
Bonvicini F; Gallinella G; Cricca M; Ambretti S; Delbarba S; Musiani M; Zerbini M
J Med Virol; 2004 Oct; 74(2):272-6. PubMed ID: 15332276
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
35. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
[TBL] [Abstract][Full Text] [Related]
36. No detection of human bocavirus in amniotic fluid samples from fetuses with hydrops or isolated effusions.
Enders M; Lindner J; Wenzel JJ; Baisch C; Schalasta G; Enders G; Modrow S
J Clin Virol; 2009 Aug; 45(4):300-3. PubMed ID: 19473872
[TBL] [Abstract][Full Text] [Related]
37. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products.
Plentz A; Hahn J; Knöll A; Holler E; Jilg W; Modrow S
Transfusion; 2005 Nov; 45(11):1811-5. PubMed ID: 16271109
[TBL] [Abstract][Full Text] [Related]
38. Fetal parvovirus B19 infection in a twin pregnancy with 1 twin presenting with hydrops fetalis and the other asymptomatic: a case report.
Leung TN; Leung TY; Chan PK; Fung TY; Lau TK
J Reprod Med; 2007 May; 52(5):419-21. PubMed ID: 17583243
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus B19 infection: association with third-trimester intrauterine fetal death.
Skjöldebrand-Sparre L; Tolfvenstam T; Papadogiannakis N; Wahren B; Broliden K; Nyman M
BJOG; 2000 Apr; 107(4):476-80. PubMed ID: 10759265
[TBL] [Abstract][Full Text] [Related]
40. Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 Cytodeath antibody.
Jordan JA; Butchko AR
Placenta; 2002 Aug; 23(7):547-53. PubMed ID: 12175970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
